• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Call Text Chat Email Refer a Patient Join a Study

Search

Hide Search
MotherToBaby

MotherToBaby

Medications and More during pregnancy and breastfeeding

Shopping Cart
Show SearchSearch
  • About
    • Our Work
    • Our Team
    • About OTIS
    • In Your Area
    • Our Partners
    • Our Impact
  • Exposures
    • Pregnancy and Breastfeeding Exposures
    • Fact Sheets
    • Baby Blogs
    • Podcasts
    • Webinars
    • Interactive Tool
    • Other Educational Tools
    • LactRx App
  • Studies
    • Ongoing Studies
    • What’s Involved?
    • Join Now
    • Refer a Patient
    • Health Providers
    • Pharma Industry
    • Publications
  • Health Professionals
    • Patient Education and Provider Resources
    • Refer a Patient
    • Request Materials
    • Annual Meeting
    • Exhibiting Schedule
    • FAQs
    • OTIS Membership
  • Media
    • Media Requests
    • Press Releases
    • eNews Sign Up
  • Donate
  • Contact
  • Show SearchSearch

Hepatitis A

April 1, 2024

Selected References:

  • Celzo F et al. 2020 Safety evaluation of adverse events following vaccination with Havrix, Engerix-B or Twinrix during pregnancy. Vaccine. 38(40):6215-6223.
  • Chilaka VN, Konje JC. 2020. Viral Hepatitis in Pregnancy. Eur J Obstet Gynecol Reprod Biol. 256:287-296.
  • Cho GJ, et al. 2013. Hepatitis A virus infection during pregnancy in Korea: Hepatitis A infection on pregnant women. Obstet Gynecol Sci, 56(6):368-374.
  • D’Acremont V, et al. 2008. Impact of vaccines given during pregnancy on the offspring of women consulting a travel clinic: a longitudinal study. J Travel Med 15(2):77-81.
  • Daudi N, et al. 2012. Breastmilk hepatitis A virus RNA in nursing mothers with acute hepatitis A virus infection. Breastfeed Med, 7:313-315.
  • Duff P. 1998. Hepatitis in Pregnancy. Seminars in Perinatology, 22(4):277-283.
  • Elinav E, et al. 2006. Acute hepatitis A infection in pregnancy is associated with high rates of gestational complications and preterm labor. Gastroenterology, 130(4):1129-1134.
  • Groom HC, et al. 2019. Uptake and safety of hepatitis A vaccination during pregnancy: A Vaccine Safety Datalink study. Vaccine, 37(44):6648-6655.
  • Lemon SM. 1997. Type A viral hepatitis: epidemiology, diagnosis, and prevention. Clin Chem, 43(8(B)):1494-1499.
  • Motte A, et al. 2009. Acute hepatitis A in pregnant women at delivery. Int J infect Dis, 13(2):e49-51.
  • Ornoy A, Tenenbaum, A. 2006. Pregnancy outcome following infections by coxsackie, echo, measles, mumps, hepatitis, polio, and encephalitis viruses. Reprod Toxicol, 21(4):446-457.
  • Panagiotou OA, et al & Costa Rica HPV Vaccine Trial (CVT) Group. 2015. Effect of bivalent human papillomavirus vaccination on pregnancy outcomes: long term observational follow-up in the Costa Rica HPV Vaccine Trial. BMJ 351:h4358457.
  • Selander B, et al. 2009. No evidence of intrauterine transmission of hepatitis A virus from a mother to a premature infant. Acta Paediatr, 98(10):1603-1606
  • Seto MT, et al. 2020. Management of viral hepatitis A, C, D and E in pregnancy. Best Pract Res Clin Obstet Gynaecol, 68:44-53.

Footer

               

Hot Links

  • Home
  • Exposures
  • Fact Sheets
  • Baby Blogs
  • Podcasts
  • Pregnancy Studies
  • Join a Study Now
  • Healthcare Professionals
  • Refer a Patient
  • Request Materials
  • News
  • Donate
  • Ask An Expert

Current Studies

  • Ankylosing Spondylitis
  • Constipation
  • Coronavirus (COVID-19)
  • Eczema (Moderate-to-Severe)/Atopic Dermatitis
  • Hidradenitis Suppurativa
  • Lupus
  • Multiple Sclerosis
  • Non-Radiographic Axial Spondyloarthritis
  • Psoriasis
  • Psoriatic Arthritis

Contact

Exposure Information Service
866.626.6847

Pregnancy Studies
877.311.8972

Media Inquiries
619.368.3259
nchavez@mothertobaby.org

MotherToBaby, a service of the Organization of Teratology Information Specialists

Copyright © 2025 The Organization of Teratology Information Specialists

  • Accessibility
  • Privacy
  • Terms
  • Site Map
^

This website is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $6,000,000 with zero percentage financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, HRSA, HHS, or the U.S. Government.